ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management, and analysis of programs that support clinical development, from compound selection to Phase I - IV clinical studies. ICON currently has approximately 8,600 employees, operating from 84 locations in 40 countries. Further information is available at www.iconplc.com